"At MultiCare Good Samaritan Hospital in Puyallup, we provide comprehensive inpatient and outpatient health care services, such as our Family Birth Center, Children's Therapy Unit, a 24-hour Emergency Department, MultiCare Regional Cancer Center, mental health program, surgical services and more. The hospital's campus includes the nine-story Dally Patient Care Tower, the state's first inpatient hospital facility to win LEED Gold certification."

During the past decade, MultiCare Good Samaritan Hospital conducted 89 clinical trials. In the 10-year time frame, 89 clinical trials started and 68 clinical trials were completed, i.e. on average, 76.4% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 46 clinical trials were completed. i.e. 176.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MultiCare Good Samaritan Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 66 trials, followed by "SWOG Cancer Research Network" with 28 trials sponsored, "Alliance for Clinical Trials in Oncology" with 17 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored and "Gynecologic Oncology Group" with 13 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MultiCare Good Samaritan Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 74 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "MultiCare Good Samaritan Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Cervical Adenocarcinoma" (8 trials), "Recurrent Breast Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Invasive Breast Carcinoma" (7 trials). Many other conditions were trialed in "MultiCare Good Samaritan Hospital" in a lesser frequency.

Most popular intervention types in "MultiCare Good Samaritan Hospital" are "Drug" (115 trials), "Other" (103 trials), "Biological" (60 trials), "Procedure" (32 trials) and "Radiation" (19 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (53 trials), "Quality-of-Life Assessment" (46 trials), "Paclitaxel" (23 trials), "Questionnaire Administration" (23 trials) and "Computed Tomography" (19 trials). Other intervention names were less common.

The vast majority of trials in "MultiCare Good Samaritan Hospital" are 111 trials for "All" genders, 35 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "MultiCare Good Samaritan Hospital". undefined are not yet recruiting, 23 are recruiting, 74 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in MultiCare Good Samaritan Hospital, 2 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in MultiCare Good Samaritan Hospital, 2 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 95 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".